9
May
2018
Fighting cancer is a team effort
/
By Dr. Peter A. Jones and Dr. Steve Baylin Co-leaders, Van Andel Research Institute–Stand Up To Cancer Epigenetics Dream Team
30
Nov
2017
Clinical trial investigates possible triple threat for lung cancer
/
A first-of-its-kind combination of medications may enable the immune system to better combat lung cancer, which claims more lives than any other... Read More
30
Dec
2016
What difference does a year make?
When it comes to biomedical research and science education, a year can make all the difference. In 2016, we celebrated Van Andel... Read More
8
Dec
2016
New hope for Parkinson’s disease
By: Patrik Brundin, M.D., Ph.D. Director of Van Andel Research Institute’s Center for Neurodegenerative Science, chairman of The Cure Parkinson’s Trust’s Linked... Read More
8
Sep
2016
Diabetes drug focus of new clinical trial for Parkinson’s disease
HIGHLIGHTS A clinical trial is now underway at Cedars-Sinai in Los Angeles to test the efficacy and safety of a type II... Read More
22
Feb
2016
Promising respiratory drug focus of new clinical trial for Parkinson’s disease
GRAND RAPIDS, Mich. (February 22, 2016)—A medication approved to treat various respiratory diseases and that has demonstrated neuroprotective effects in preclinical studies... Read More